Style | Citing Format |
---|---|
MLA | Saeidnia S, Gohari AR, Manayi A. "Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development." Current Pharmaceutical Biotechnology, vol. 17, no. 11, 2016, pp. 1016-1022. |
APA | Saeidnia S, Gohari AR, Manayi A (2016). Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development. Current Pharmaceutical Biotechnology, 17(11), 1016-1022. |
Chicago | Saeidnia S, Gohari AR, Manayi A. "Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development." Current Pharmaceutical Biotechnology 17, no. 11 (2016): 1016-1022. |
Harvard | Saeidnia S, Gohari AR, Manayi A (2016) 'Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development', Current Pharmaceutical Biotechnology, 17(11), pp. 1016-1022. |
Vancouver | Saeidnia S, Gohari AR, Manayi A. Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development. Current Pharmaceutical Biotechnology. 2016;17(11):1016-1022. |
BibTex | @article{ author = {Saeidnia S and Gohari AR and Manayi A}, title = {Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development}, journal = {Current Pharmaceutical Biotechnology}, volume = {17}, number = {11}, pages = {1016-1022}, year = {2016} } |
RIS | TY - JOUR AU - Saeidnia S AU - Gohari AR AU - Manayi A TI - Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development JO - Current Pharmaceutical Biotechnology VL - 17 IS - 11 SP - 1016 EP - 1022 PY - 2016 ER - |